| Results Pfizer and partner company BioNTech self-reported on Wednesday indicate the vaccine in development by the two companies has an efficacy rate of 95 percent. This comes on the heels of an announcement earlier this month that its shots were more than 90 percent effective. Drug company Moderna also has a candidate vaccine that is showing similar, self-reported results. The next hurdle is taking these potential vaccines to the Federal Drug Administration for further review. |  |
News Alert Wednesday, November 18 |
|
|  | | Pfizer, now saying its candidate COVID-19 vaccine is 95% effective, plans to start FDA approval process 'within days' | | Results Pfizer and partner company BioNTech self-reported on Wednesday indicate the vaccine in development by the two companies has an efficacy rate of 95 percent. This comes on the heels of an announcement earlier this month that its shots were more than 90 percent effective. Drug company Moderna also has a candidate vaccine that is showing similar, self-reported results. The next hurdle is taking these potential vaccines to the Federal Drug Administration for further review. | | |
|
| | | | | | |
|
